| HOME >> BIOLOGY >> TECHNOLOGY |
nine months per GAAP $166.5 $124.6
Net earnings during the 4th quarter
of 2006 per GAAP 62.3 62.3
Adjustments during the 4th quarter of 2006 3.5 3.5
Adjustments during the first nine months (27.8) (6.2)
Adjusted net earnings 204.5 184.2
Interest for the first nine months
(reported) 38.9 39.0
Interest for the 4th quarter of 2006
(reported) 11.7 11.7
Adjustments to interest (0.8) (2.7)
Adjusted interest 49.8 48.0
Taxes for the first nine months (reported) 63.5 35.4
Taxes for the 4th quarter of 2006
(reported) 21.6 21.6
Adjustments to taxes (11.6) 15.5
Adjusted taxes 73.5 72.5
Depreciation & amortization (reported) 203.7 165.7
Adjusted EBITDA $531.5 $470.4
Reconciliation of GAAP Cash Flow Provided by Operating Activities to Free Cash Flow
Nine Months Ended Nine Months Ended
September 30, 2007 September 30, 2006
Net cash flow provided by
operating activities $284.7 $213.1
Additions to property, plant and
equipment (223.4) (207.4)
Free cash flow $61.3 $5.7
* See accompanying Non-GAAP Financial Measures section for
description of Non-GAAP adjustments.
Contact: Robert Raynor
<| SOURCE Beckman Coulter, Inc. Copyright©2007 PR Newswire. All rights reserved |